NUCLISENS EASYQ MRSA; NUCLISENS EASYQ ANALYZER; NUCLISENS EASYQ INCUBATOR (110 VOLT); NUCLISENS DIRECTOR V.2.6

System, Nucleic Acid Amplification Test, Dna, Methicillin Resistant Staphylococcus Aureus, Direct Specimen

BIOMERIEUX, INC.

The following data is part of a premarket notification filed by Biomerieux, Inc. with the FDA for Nuclisens Easyq Mrsa; Nuclisens Easyq Analyzer; Nuclisens Easyq Incubator (110 Volt); Nuclisens Director V.2.6.

Pre-market Notification Details

Device IDK102740
510k NumberK102740
Device Name:NUCLISENS EASYQ MRSA; NUCLISENS EASYQ ANALYZER; NUCLISENS EASYQ INCUBATOR (110 VOLT); NUCLISENS DIRECTOR V.2.6
ClassificationSystem, Nucleic Acid Amplification Test, Dna, Methicillin Resistant Staphylococcus Aureus, Direct Specimen
Applicant BIOMERIEUX, INC. 100 RODOLPHE ST Durham,  NC  27712
ContactJocelyn Jennings
CorrespondentJocelyn Jennings
BIOMERIEUX, INC. 100 RODOLPHE ST Durham,  NC  27712
Product CodeNQX  
CFR Regulation Number866.1640 [🔎]
DecisionSubstantially Equivalent (SESE)
TypeTraditional
3rd Party ReviewedNo
Combination ProductNo
Date Received2010-09-22
Decision Date2011-05-20
Summary:summary

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.